These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 12107245)

  • 1. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
    Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific dysregulation of cortisol metabolism in human obesity.
    Rask E; Olsson T; Söderberg S; Andrew R; Livingstone DE; Johnson O; Walker BR
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
    Westerbacka J; Yki-Järvinen H; Vehkavaara S; Häkkinen AM; Andrew R; Wake DJ; Seckl JR; Walker BR
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
    Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
    Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
    Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM; Toogood AA; Tomlinson JW
    Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
    Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
    Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
    Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
    Finken MJ; Andrews RC; Andrew R; Walker BR
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men.
    Stimson RH; Johnstone AM; Homer NZ; Wake DJ; Morton NM; Andrew R; Lobley GE; Walker BR
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4480-4. PubMed ID: 17785367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance.
    Andrews RC; Herlihy O; Livingstone DE; Andrew R; Walker BR
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5587-93. PubMed ID: 12466357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
    Draper N; Echwald SM; Lavery GG; Walker EA; Fraser R; Davies E; Sørensen TI; Astrup A; Adamski J; Hewison M; Connell JM; Pedersen O; Stewart PM
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4984-90. PubMed ID: 12414862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity.
    Wake DJ; Rask E; Livingstone DE; Söderberg S; Olsson T; Walker BR
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3983-8. PubMed ID: 12915696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
    J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study.
    Pasquali R; Ambrosi B; Armanini D; Cavagnini F; Uberti ED; Del Rio G; de Pergola G; Maccario M; Mantero F; Marugo M; Rotella CM; Vettor R;
    J Clin Endocrinol Metab; 2002 Jan; 87(1):166-75. PubMed ID: 11788642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.